American Journal of Ophthalmology
Volume 150, Issue 3 , Pages 352-359.e2 , September 2010

The Effect of Topical Autologous Serum on Graft Re-epithelialization After Penetrating Keratoplasty

  • Yan-Ming Chen

      Affiliations

    • Department of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan
    • National Taiwan University College of Medicine, Taipei, Taiwan
    • Department of Ophthalmology, E-Da Hospital/I-Shou University, Kaohsiung County, Taiwan
    • ,
  • Fung-Rong Hu

      Affiliations

    • Department of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan
    • Center of Corneal Tissue Engineering and Stem Cell Biology, National Taiwan University Hospital, Taipei, Taiwan
    • ,
  • Jehn-Yu Huang

      Affiliations

    • Department of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan
    • ,
  • Elizabeth P. Shen

      Affiliations

    • Department of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan
    • National Taiwan University College of Medicine, Taipei, Taiwan
    • Department of Ophthalmology, Buddhist Tzu Chi General Hospital, Taipei Branch, Taipei, Taiwan
    • ,
  • Tzu-Yun Tsai

      Affiliations

    • Department of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan
    • National Taiwan University College of Medicine, Taipei, Taiwan
    • ,
  • Wei-Li Chen

      Affiliations

    • Department of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan
    • Center of Corneal Tissue Engineering and Stem Cell Biology, National Taiwan University Hospital, Taipei, Taiwan
    • Corresponding Author InformationInquiries to Wei-Li Chen, Department of Ophthalmology, National Taiwan University Hospital, No. 7, Chung-Shan South Road, Taipei, Taiwan

,Accepted 24 March 2010.

References 

  1. Dellaert MM, Casey TA, Wiffen S, et al. Influence of topical human epidermal growth factor on postkeratoplasty re-epithelialisation. Br J Ophthalmol. 1997;81(5):391–395
  2. Hori J, Streilein JW. Dynamics of donor cell persistence and recipient cell replacement in orthotopic corneal allografts in mice. Invest Ophthalmol Vis Sci. 2001;42(8):1820–1828
  3. Yeh PT, Hou YC, Lin WC, et al. Recurrent corneal perforation and acute calcareous corneal degeneration in chronic graft-versus-host disease. J Formos Med Assoc. 2006;105(4):334–339
  4. Seitz B, Das S, Sauer R, et al. Amniotic membrane transplantation for persistent corneal epithelial defects in eyes after penetrating keratoplasty. Eye. 2009;23(4):840–848
  5. Borderie VM, Touzeau O, Bourcier T, et al. Graft re-epithelialization after penetrating keratoplasty using organ-cultured donor tissue. Ophthalmology. 2006;113(12):2181–2186
  6. del Castillo JM, de la Casa JM, Sardiña RC, et al. Treatment of recurrent corneal erosions using autologous serum. Cornea. 2002;21(8):781–783
  7. Tsubota K, Goto E, Shimmura S, Shimazaki J. Treatment of persistent corneal epithelial defect by autologous serum application. Ophthalmology. 1999;106(10):1984–1989
  8. Mukerji N, Sinha R, Vajpayee RB. Role of autologous serum in persistent epithelial defects. Br J Ophthalmol. 2002;86(7):832
  9. Schrader S, Wedel T, Moll R, Geerling G. Combination of serum eye drops with hydrogel bandage contact lenses in the treatment of persistent epithelial defects. Graefes Arch Clin Exp Ophthalmol. 2006;244(10):1345–1349
  10. Chiang CC, Chen WL, Lin JM, Tsai YY. Allogeneic serum eye drops for the treatment of persistent corneal epithelial defect. Eye. 2009;23(2):290–293
  11. Goto E, Shimmura S, Shimazaki J, Tsubota K. Treatment of superior limbic keratoconjunctivitis by application of autologous serum. Cornea. 2001;20(8):807–810
  12. Tsubota K, Goto E, Fujita H, et al. Treatment of dry eye by autologous serum application in Sjögren's syndrome. Br J Ophthalmol. 1999;83(4):390–395
  13. Poon AC, Geerling G, Dart JK, et al. Autologous serum eyedrops for dry eyes and epithelial defects: clinical and in vitro toxicity studies. Br J Ophthalmol. 2001;85(10):1188–1197
  14. Matsumoto Y, Dogru M, Goto E, et al. Autologous serum application in the treatment of neurotrophic keratopathy. Ophthalmology. 2004;111(6):1115–1120
  15. Esquenazi S, He J, Bazan HE, Bazan NG. Use of autologous serum in corneal epithelial defects post-lamellar surgery. Cornea. 2005;24(8):992–997
  16. Schulze SD, Sekundo W, Kroll P. Autologous serum for the treatment of corneal epithelial abrasions in diabetic patients undergoing vitrectomy. Am J Ophthalmol. 2006;142(2):207–211
  17. Liu L, Hartwig D, Harloff S, et al. An optimised protocol for the production of autologous serum eyedrops. Graefes Arch Clin Exp Ophthalmol. 2005;243(7):706–714
  18. Liu L, Hartwig D, Harloff S, et al. Corneal epitheliotrophic capacity of three different blood-derived preparations. Invest Ophthalmol Vis Sci. 2006;47(6):2438–2444
  19. Palmer RM, Kaufman HE. Tear film, pharmacology of eye drops, and toxicity. Curr Opin Ophthalmol. 1995;6(4):11–16
  20. Kaszli FA, Krieglstein GK. Tear film deficiencies pharmacology of eye drops and toxicity. Curr Opin Ophthalmol. 1996;7(4):12–16
  21. Labbe A, Pauly A, Liang H, et al. Comparison of toxicological profiles of benzalkonium chloride and polyquaternium-1: an experimental study. J Ocul Pharmacol Ther. 2006;22(4):267–278
  22. Vajpayee RB, Mukerji N, Tandon R, et al. Evaluation of umbilical cord serum therapy for persistent corneal epithelial defects. Br J Ophthalmol. 2003;87(11):1312–1316
  23. Eye Bank Association of America. Procedures Manual. Washington, DC: Eye Bank Association of America; 2002;
  24. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2007;30(suppl 1):42–47
  25. Hu FR, Tsai AC, Wang IJ, Chang SW. Outcomes of penetrating keratoplasty with imported donor corneas. Cornea. 1999;18(2):182–187
  26. Chou L, Cohen EJ, Laibson PR, Rapuano CJ. Factors associated with epithelial defects after penetrating keratoplasty. Ophthalmic Surg. 1994;25(10):700–703
  27. Cheour M, Nasri H, Kamoun H, et al. Factors associated with graft re-epithelialization after penetrating keratoplasty. J Fr Ophtalmol. 2008;31(8):786–789
  28. Kim T, Palay DA, Lynn M. Donor factors associated with epithelial defects after penetrating keratoplasty. Cornea. 1996;15(5):451–456
  29. Shimazaki J, Saito H, Yang HY, et al. Persistent epithelial defect following penetrating keratoplasty: an adverse effect of diclofenac eyedrops. Cornea. 1995;14(6):623–627
  30. Schultz RO, Van Horn DL, Peters MA, et al. Diabetic keratopathy. Trans Am Ophthalmol Soc. 1981;79:180–199
  31. Friend J, Ishii Y, Thoft RA. Corneal epithelial changes in diabetic rats. Ophthalmic Res. 1982;14(4):269–278
  32. Herse PR. A review of manifestations of diabetes mellitus in the anterior eye and cornea. Am J Optom Physiol Opt. 1988;65(3):224–230
  33. Rosenberg ME, Tervo TM, Immonen IJ, et al. Corneal structure and sensitivity in type 1 diabetes mellitus. Invest Ophthalmol Vis Sci. 2000;41(10):2915–2921
  34. Saghizadeh M, Chwa M, Aoki A, et al. Altered expression of growth factors and cytokines in keratoconus, bullous keratopathy and diabetic human corneas. Exp Eye Res. 2001;73(2):179–189
  35. Gobbels M, Spitznas M, Oldendoerp J. Impairment of corneal epithelial barrier function in diabetics. Graefes Arch Clin Exp Ophthalmol. 1989;227(2):142–144
  36. Yokoi N, Niiya A, Komuro A, et al. Effects of aldose reductase inhibitor CT-112 on the corneal epithelial barrier of galactose-fed rats. Curr Eye Res. 1997;16(6):595–599
  37. Gekka M, Miyata K, Nagai Y, et al. Corneal epithelial barrier function in diabetic patients. Cornea. 2004;23(1):35–37
  38. Meyer RF, Bobb KC. Corneal epithelium in penetrating keratoplasty. Am J Ophthalmol. 1980;90(2):142–147
  39. Tsubota K, Yamada M. The effect of aldose reductase inhibitor on the corneal epithelium. Cornea. 1993;12(2):161–162
  40. Ohguro N, Matsuda M, Ohashi Y, Fukuda M. Topical aldose reductase inhibitor for correcting corneal endothelial changes in diabetic patients. Br J Ophthalmol. 1995;79(12):1074–1077
  41. Taylor HR, Kimsey RA. Corneal epithelial basement membrane changes in diabetes. Invest Ophthalmol Vis Sci. 1981;20(4):548–553
  42. Hatchell DL, Magolan JJ, Besson MJ, et al. Damage to the epithelial basement membrane in the corneas of diabetic rabbits. Arch Ophthalmol. 1983;101(3):469–471
  43. Azar DT, Spurr-Michaud SJ, Tisdale AS, Gipson IK. Altered epithelial-basement membrane interactions in diabetic corneas. Arch Ophthalmol. 1992;110(4):537–540
  44. Cousen P, Cackett P, Bennett H, et al. Tear production and corneal sensitivity in diabetes. J Diabetes Complications. 2007;21(6):371–373
  45. Chen WL, Lin CT, Ko PS, et al. In vivo confocal microscopic findings of corneal wound healing after corneal epithelial debridement in diabetic vitrectomy. Ophthalmology. 2009;116(6):1038–1047
  46. Reed DB, Mannis MJ, Hills JF, Johnson CA. Corneal epithelial healing after penetrating keratoplasty using topical Healon versus balanced salt solution. Ophthalmic Surg. 1987;18(7):525–528
  47. Wilson SE, Kaufman HE. Graft failure after penetrating keratoplasty. Surv Ophthalmol. 1990;34(5):325–356
  48. Rosenthal P, Cotter JM, Baum J. Treatment of persistent corneal epithelial defect with extended wear of a fluid-ventilated gas-permeable scleral contact lens. Am J Ophthalmol. 2000;130(1):33–41
  49. Arora R, Gupta S, Taneja M, Raina UK, Mehta DK. Disposable contact lenses in penetrating keratoplasty. CLAO J. 2000;26(3):127–129
  50. Imayasu M, Petroll WM, Jester JV, Patel SK, Ohashi J, Cavanagh HD. The relation between contact lens oxygen transmissibility and binding of Pseudomonas aeruginosa to the cornea after overnight wear. Ophthalmology. 1994;101(2):371–388
  51. Liesegang TJ. Physiologic changes of the cornea with contact lens wear. CLAO J. 2002;28(1):12–27
  52. Höflin-Lima AL, Roizenblatt R. Therapeutic contact lens-related bilateral fungal keratitis. CLAO J. 2002;28(3):149–150
  53. Chan JC, Malik V, Jia W, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA. 2009;301(20):2129–2140
  54. Western Pacific Declaration on Diabetes Steering Committee. Plan of action for the Western Pacific Declaration on Diabetes 2006-2010. Western Pacific Declaration on Diabetes Web site http://www.wpdd.org/downloads/WPDD_PoA_2010.pdfAccessed December 5, 2009
  55. Wong KC, Wang Z. Prevalence of type 2 diabetes mellitus of Chinese populations in Mainland China, Hong Kong, and Taiwan. Diabetes Res Clin Pract. 2006;73(2):126–134
  56. Su DH, Wong TY, Wong WL, et al. Diabetes, hyperglycemia, and central corneal thickness: the Singapore Malay Eye Study. Ophthalmology. 2008;115(6):964–968

PII: S0002-9394(10)00249-7

doi: 10.1016/j.ajo.2010.03.024

American Journal of Ophthalmology
Volume 150, Issue 3 , Pages 352-359.e2 , September 2010

Article Tools

* Image Usage & Resolution